Mr. Preuss has 25 years’ executive level, health care services experience. With 10 years’ value-based reimbursement and physician practice management leadership, he was a senior / founding executive at Viva Health, a Clinician driven HMO and primary care PPM. As CEO of a leading national hospice company for 10 years, Jeff has deep post-acute experience and was responsible for more than 1,000 employees in eight states. Previously he spent eight years as Practice Leader for the Middle Market Consulting Group at Deloitte & Touche in Boston.
Chip has 20 years’ acquisition, sales and health care leadership experience. Mr. Dempsey was Sr. V.P., Acquisitions & Strategic Investments for PSS World Medical, where he oversaw roughly 30 acquisitions and $375m revenue. His expertise includes primary care market and health care business development operations for companies such as Beckman Coulter and PSS World Medical, from inception through acquisition by Welsh Carson and McKesson.
Mr. Mihnovich most recently served as CFO of the 700 MD University of Louisville Physician Group. His understanding of complex practice issues, financial reporting and management is key to driving manageable growth, efficient operations and consistent results. Previously, Jim served as a Senior Finance and Accounting Director for Lifepoint Health Physician’s and HCA Physicians Services, serving several thousand Clinicians with reporting responsibility for $1 billion combined revenue.
John Farley, MD
As a fourth-generation physician and founder of a large primary-care practice, Dr. John Farley has been working for more than 20 years to improve the way physicians practice medicine with a focus on improving health outcomes. In addition to being President of Birmingham Internal Medicine Associates, Dr. Farley has also served as Medical Director for Ascension / St. Vincent’s Birmingham primary-care clinics. As Chief Medical Officer, Dr. Farley oversees all Complete Health programs related to quality patient care.
Mrs. Marsden brings more than 20 years of experience in the clinical research industry and holds several professional certifications. Since 2009, she has been the lead executive of an operation acclaimed by sponsors and regulators as a model facility. She actively oversees research sites in multiple states. Kim has been involved in all aspects of more than 300 phase I – phase IV clinical trials. She manages trials and site personnel from pre-study planning, contract and proposal development, through successful completion.